Both CD133+ and CD133- subpopulations of A549 and H446 cells contain cancer-initiating cells

Cancer Science

Volumn 100, Issue 6, 2009, Pages 1040-1046

  Meng, Xiangjiao ^a   Li, Ming ^a   Wang, Xiuwen ^a   Wang, Yawei ^a   Ma, Daoxin ^b  

^a Chemotherapy   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CISPLATIN; ETOPOSIDE; GEMCITABINE; PACLITAXEL; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER RESISTANCE; CANCER STEM CELL; CELL ASSAY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL REGENERATION; CELL RENEWAL; CELL SELECTION; CELL STRAIN A549; CELL STRAIN H446; CELL SUBPOPULATION; COLONY FORMATION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; LUNG CANCER; MAGNETIC SEPARATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR VOLUME; ANIMAL; CELL SEPARATION; CLASSIFICATION; CLONOGENIC ASSAY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG TUMOR; METHODOLOGY; PATHOLOGY; REGENERATION; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANTIGENS, CD; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL SEPARATION; COLONY-FORMING UNITS ASSAY; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MICE; NEOPLASTIC STEM CELLS; PEPTIDES; REGENERATION; SMALL CELL LUNG CARCINOMA; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 67649890779     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01144.x     Document Type: Article

References (23)

1. Miraglia S, Godfrey W, Yin AH. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997, 90:5013-21.
2. Yin AH, Miraglia S, Zanjani ED. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997, 90:5002-12.
3. Singh SK, Clarke ID, Terasaki M. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003, 63:5821-8.
4. Singh SK, Hawkins C, Clarke D. Identification of human brain tumor initiating cells. Nature 2004, 432:396-401.
5. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005, 65:10946-51.
6. Suetsugu A, Nagaki M, Aoki H. Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun 2006, 351:820-4.
7. Yin S, Li J, Hu C. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer 2007, 120:1444-50.
8. Hermann PC, Huber SL, Herrier T. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007, 1:313-23.
9. O'Brien CA, Pollett A, Gallinger S. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-10.
10. Ricci-Vitiani L, Lombardi DG, Pilozzi E. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-5.
11. Monzani E, Facchetti F, Galmozzo E. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer 2007, 43:935-46.
12. Eramo A, Lotti F, Sette G. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008, 15:504-14.
13. Beier D, Hau P, Proescholdt M. CD133 (+) and CD133 (-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 2007, 67:4010-5.
14. Shmelkov SV, Butler JM, Hooper AT. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 2008, 118:2111-20.
15. Srivastava VK, Nalbantoglu J. Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype. Cytometry A 2008, 73:940-8.
16. Zheng X, Shen G, Yang X, Liu W. Most C6 cells are cancer stem cells: evidence from clonal and population analyses. (Published erratum appears in. Cancer Res 2007, 67:3691-7.
17. Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003, 3:895-902.
18. Eramo A, Ricci-Vitiani L, Zeuner A. Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ 2006, 13:1238-41.
19. Liu G, Yuan X, Zeng Z. Analyses of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006, 2(5):67.
20. Albini A, Iwamoto Y, Kleinman HK. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987, 47:3239-45.
21. Heppner GH. Tumor heterogeneity. Cancer Res 1984, 44(6):2259-65.
22. Weisenthal LM, Lippman ME. Clonogenic and nonclonogenic in vitro chemosensitivity assays. Cancer Treat Rep 1985, 69:615-32.
23. Al-Hajj M, Wiclla MS, Benito-Hernandez A. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003, 100:3983-8.